COVID-19 is dangerous for middle-aged adults, not just the elderly

January 21, 2021

COVID-19 has been spreading rapidly over the past several months, and the U.S. death toll has now reached 400,000. As evident from the age distribution of those fatalities, COVID-19 is dangerous not only for the elderly but for middle-aged adults, according to a Dartmouth-led study published in the European Journal of Epidemiology.

"For a person who is middle-aged, the risk of dying from COVID-19 is about 100 times greater than dying from an automobile accident," explains lead author Andrew Levin, a professor of economics at Dartmouth College. "Generally speaking, very few children and young adults die of COVID-19. However, the risk is progressively greater for middle-aged and older adults. The odds that an infection becomes fatal is only 1:10,000 at age 25, whereas those odds are roughly 1:100 at age 60, 1:40 at age 70, and 1:10 at age 80."

These findings represent the culmination of a systematic review of all available studies of COVID-19 prevalence in countries with advanced economies; this review encompassed more than 1,000 research papers and government documents disseminated prior to September 18, 2020. The research team identified 27 studies where the survey design was representative of the general population, covering 34 geographical locations in the U.S., Canada, Asia, and Europe. Using those prevalence data, the researchers investigated the age-specific ratio of COVID-19 fatalities to infections and found a very clear exponential relationship.

An initial version of this study was posted online in July 2020 as an NBER Working Paper and was regularly updated on the medRxiv preprint server prior to being published as an open-access article in the European Journal of Epidemiology. The findings remain highly relevant as the total number of COVID-19 deaths in the U.S. continues to climb. "Our findings are consistent with the CDC's Weekly Updates by Select Demographic and Geographic Characteristics, which report on COVID-19 deaths by age group," says Levin. "Nearly 40 percent of U.S. COVID-19 deaths have occurred among those ages 45 to 74 years, while almost 60 percent have occurred among those over 75 years old. By contrast, children and young adults (less than 45 years old) account for less than 3 percent of U.S. COVID-19 deaths."

Levin also emphasized the urgent practical implications of his team's research findings. "While COVID-19 vaccines are now being distributed, several more months are likely to pass before these vaccines have been fully disseminated to the public," says Levin. "We need get through this period as safely as possible. Taking basic precautions--including wearing a mask, practicing social distancing, and washing your hands often--is critical to protecting yourself, family, friends, and community members from this very deadly disease."
Levin is available for comment at: The study was co-authored by William P. Hanage at the Harvard T.H. Chan School of Public Health, Nana Owusu-Boaitey at Case Western Reserve University School of Medicine, Gideon Meyerowitz-Katz at the University of Wollongong, and recent Dartmouth graduates Kensington B. Cochran '20 and Seamus P. Walsh '20.

Dartmouth College

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to